DMK
SIOX

David M. Knott’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

David M. Knott’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$174K Hold
80,000
– – 0.06% 101
2021
Q2 		$218K Buy
80,000
+10,000
+14% +$24.9K 0.08% 97
2021
Q1 		$183K Buy
70,000
+30,000
+75% +$84.9K 0.08% 88
2020
Q4 		$111K Buy
+40,000
New +$116K 0.05% 82

Other funds holding SIOX

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

David M. Knott's SIOX Position: Q3 2021 in Review

David M. Knott held its Sio Gene Therapies Inc. Common Stock (SIOX) position steady in Q3 2021 at 80,000 shares worth $174K. The position accounts for 0.06% of the portfolio, ranked #101.

David M. Knott first reported a position in SIOX in Q4 2020 and has held it in 4 quarters since. The position peaked at $218K in Q2 2021. 56 funds tracked by Wall St. Rank hold SIOX as of Q3 2021.

  • David M. Knott held 80,000 shares of Sio Gene Therapies Inc. Common Stock worth $174K as of Q3 2021.
  • David M. Knott left its Sio Gene Therapies Inc. Common Stock share count unchanged in Q3 2021.
  • Sio Gene Therapies Inc. Common Stock made up 0.06% of David M. Knott's portfolio in Q3 2021, its #101 holding.
  • David M. Knott first reported a position in Sio Gene Therapies Inc. Common Stock in Q4 2020 and has held it in 4 quarters since.
  • David M. Knott's Sio Gene Therapies Inc. Common Stock position peaked at $218K in Q2 2021.
  • 56 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q3 2021.

Based on David M. Knott's 13F filing for Q3 2021, filed 12 Nov 2021.